Loading the map…

Management consultancy activities other than financial management · Glasgow, City Of Glasgow

Ms4pharma

Ms4pharma Ltd

Net liabilitiesActiveLatest figures: 2025Abridged accountsCompany only3 years on the register

Private limited company registered in Glasgow, classed under “Management consultancy activities other than financial management”.

Headline figures

FY to May 2025 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

What the numbers say

3 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£20242025
Profit after tax—
Turnover
Net assets
Cash
Employees
Retained reserves

Every figure for all 2 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet20242025
Current assets
of which cash
Net current assets
Net assets

4 balance-sheet lines, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Questions people ask

›What does Ms4pharma do?

Private limited company registered in Glasgow, classed under “Management consultancy activities other than financial management”.

›How much turnover does Ms4pharma make?

Answered in the full report

›Is Ms4pharma profitable?

Ms4pharma's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Ms4pharma?

Answered in the full report

›Where is Ms4pharma based?

Its registered office is Suite 4.1, 25 Bothwell Street, C/O Hawthorn Tax, Glasgow, City Of Glasgow, G2 6NL, in Glasgow, City Of Glasgow.

›When was Ms4pharma founded?

Ms4pharma Ltd was incorporated on 12 May 2023.

›Is Ms4pharma still trading?

The register lists Ms4pharma Ltd as active.